Laurion Capital Management LP Nevro Corp Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $6.49 Million - $12.3 Million	-158,917 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $9.53 Million - $14.6 Million	158,917 New	158,917 $11.5 Million
Q1 2020 May 14, 2020	SELL	$70.23 - $144.31 $1.07 Million - $2.2 Million	-15,241 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$76.41 - $117.54 $1.16 Million - $1.79 Million	15,241 New	15,241 $1.79 Million
Q1 2018 May 14, 2018	SELL	$69.46 - $88.57 $333,407 - $425,135	-4,800 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$65.94 - $93.31 $316,512 - $447,888	4,800	4,800 $331,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $131M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.